Global Heparin Market to Reach US$14.3 by 2023, Rising Incidence of Coagulation Disorders to act as Growth Driver Transparency Market Research (TMR) has recently published a research report on the global heparin market for , which estimates the market to rise at a CAGR of 6.30% over the period from 2015 to 2023 and reach a value of US$14.3 bn by the end of the forecast period. The market study, titled “Heparin Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 2023,� states that the worldwide heparin market stood at US$8.2 bn in 2014. Heparin is an injectable blood thinner, utilized for the treatment of deep vein thrombosis (DVT) and pulmonary embolism. It is also employed as part of the treatment of unstable angina and myocardial infarction. The increasing incidence of coagulation disorders is propelling the demand for heparin significantly across the world. The global heparin market has been analyzed on the basis of product in this research report. Ultra-low molecular weight heparin (ULMWHs), low molecular weight heparin (LMWHs),